Those who received bariatric surgery had considerably fewer major cardiovascular events in the years that followed, according to a Rutgers research of obese individuals with nonalcoholic fatty liver disease (NAFLD) and morbid obesity.
“The findings provide evidence in support of bariatric surgery as an effective therapeutic tool to lower elevated risk of cardiovascular disease for select individuals with obesity and NAFLD,” said Vinod K. Rustgi, Distinguished Professor of Medicine, clinical director of Hepatology and director of the Center for Liver Diseases and Liver Masses at Rutgers Robert Wood Johnson Medical School. “These findings are tremendously impactful for many reasons.”
Data on outcomes from 2007 to 2017 were evaluated by researchers using the MarketScan Commercial Claims and Encounters medical insurance database. Out of 230 million people that were covered, 86,964 adults between the ages of 18 and 64 were found to have obesity and NAFLD. In this group, 68% of the participants were female, 35% got bariatric surgery, and 65% received nonsurgical therapy.
Major cardiovascular events including heart attacks, heart failure, or ischemic strokes were 49 percent less likely to occur in people who had bariatric surgery. Additionally, they were significantly less likely to develop arterial blood clots, atherosclerotic events, or angina.
Visit us on: thespeednews.com